Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Wegrzynowicz

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Brain : a Journal of Neurology|October 4, 2017
The L444P Gba1 mutation enhances alpha-synuclein induced loss of nigral dopaminergic neurons in miceAnna Migdalska-Richards, Michal Wegrzynowicz, Raffaella Rusconi, et al.
Brain : a Journal of Neurology|March 24, 2021
CSPα reduces aggregates and rescues striatal dopamine release in α-synuclein transgenic miceLaura Caló, Eric Hidari, Michal Wegrzynowicz, et al.
Journal of Neurochemistry|October 23, 2009
Disease-toxicant screen reveals a neuroprotective interaction between Huntington's disease and manganese exposureB Blairanne Williams, Daphne Li, Michal Wegrzynowicz, et al.
Acta Neuropathologica|June 6, 2019
Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease modelMichal Wegrzynowicz, Dana Bar-On, Laura Calo', et al.
Ebiomedicine|May 2, 2022
Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trialJohannes Levin, Nand Sing, Sue Melbourne, et al.
Communications Biology|December 11, 2021
Potent but transient immunosuppression of T-cells is a general feature of CD71<sup>+</sup> erythroid cellsTomasz M Grzywa, Anna Sosnowska, Zuzanna Rydzynska, et al.
Journal of Huntington'S Disease|September 4, 2015
Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative PhenotypeMichal Wegrzynowicz, Terry Jo Bichell, Barbara D Soares, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|February 19, 2017
Reduced bioavailable manganese causes striatal urea cycle pathology in Huntington's disease mouse modelTerry Jo V Bichell, Michal Wegrzynowicz, K Grace Tipps, et al.
Biological Psychiatry|September 23, 2015
Alpha-Synuclein Produces Early Behavioral Alterations via Striatal Cholinergic Synaptic Dysfunction by Interacting With GluN2D N-Methyl-D-Aspartate Receptor SubunitAlessandro Tozzi, Antonio de Iure, Vincenza Bagetta, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Brain : a Journal of Neurology|October 4, 2017
The L444P Gba1 mutation enhances alpha-synuclein induced loss of nigral dopaminergic neurons in miceAnna Migdalska-Richards, Michal Wegrzynowicz, Raffaella Rusconi, et al.
Brain : a Journal of Neurology|March 24, 2021
CSPα reduces aggregates and rescues striatal dopamine release in α-synuclein transgenic miceLaura Caló, Eric Hidari, Michal Wegrzynowicz, et al.
Journal of Neurochemistry|October 23, 2009
Disease-toxicant screen reveals a neuroprotective interaction between Huntington's disease and manganese exposureB Blairanne Williams, Daphne Li, Michal Wegrzynowicz, et al.
Acta Neuropathologica|June 6, 2019
Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease modelMichal Wegrzynowicz, Dana Bar-On, Laura Calo', et al.
Ebiomedicine|May 2, 2022
Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trialJohannes Levin, Nand Sing, Sue Melbourne, et al.
Communications Biology|December 11, 2021
Potent but transient immunosuppression of T-cells is a general feature of CD71<sup>+</sup> erythroid cellsTomasz M Grzywa, Anna Sosnowska, Zuzanna Rydzynska, et al.
Journal of Huntington'S Disease|September 4, 2015
Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative PhenotypeMichal Wegrzynowicz, Terry Jo Bichell, Barbara D Soares, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|February 19, 2017
Reduced bioavailable manganese causes striatal urea cycle pathology in Huntington's disease mouse modelTerry Jo V Bichell, Michal Wegrzynowicz, K Grace Tipps, et al.
Biological Psychiatry|September 23, 2015
Alpha-Synuclein Produces Early Behavioral Alterations via Striatal Cholinergic Synaptic Dysfunction by Interacting With GluN2D N-Methyl-D-Aspartate Receptor SubunitAlessandro Tozzi, Antonio de Iure, Vincenza Bagetta, et al.
Pageof 2